VBI Vaccines to Present at the Canaccord Genuity 39th Annual Growth Conference
05 août 2019 08h00 HE
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., Aug. 05, 2019 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq: VBIV) ("VBI"), a commercial-stage biopharmaceutical company developing next-generation infectious disease and...